Identification of peroxisome proliferator-activated receptor ligands from a biased chemical library-Reference-Cited by-同舟云学术

Identification of peroxisome proliferator-activated receptor ligands from a biased chemical library

Published:1997-12 Issue:12 Volume:4 Page:909-918
ISSN:1074-5521
Container-title:Chemistry & Biology
language:en
Short-container-title:Chemistry & Biology

Author:

Brown Peter J.,Smith-Oliver Tracey A.,Charifson Paul S.,Tomkinson Nicholas C.O.,Fivush Adam M.,Sternbach Daniel D.,Wade Laura E.,Orband-Miller Lisa,Parks Derek J.,Blanchard Steven G.,Kliewer Steven A.,Lehmann Jürgen M.,Willson Timothy M.

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,General Medicine,Biochemistry

Reference35 articles.

1. The RXR heterodimers and orphan receptors;Mangelsdorf;Cell,1995

2. Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology;Lemberger;Annu. Rev. Cell Dev. Biol.,1996

3. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors;Kliewer,1994

4. Peroxisome proliferator-activated receptor agonists;Willson;Curr. Opin. Chem. Biol.,1997

5. Peroxisome proliferator-activated receptors, orphans with ligands and functions;Schoonjans;Curr. Opin. Lipidol.,1997

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accumulation of Linoleic Acid by Altered Peroxisome Proliferator-Activated Receptor-α Signaling Is Associated with Age-Dependent Hepatocarcinogenesis in Ppara Transgenic Mice;Metabolites;2023-08-10

2. Promising biomarkers and therapeutic targets for the management of Parkinson's disease: recent advancements and contemporary research;Metabolic Brain Disease;2023-02-20

3. Emerging Therapeutic Strategies for Parkinson’s Disease and Future Prospects: A 2021 Update;Biomedicines;2022-02-03

4. Design, Synthesis, and Biological Evaluation of Triazolone Derivatives as Potent PPARα/δ Dual Agonists for the Treatment of Nonalcoholic Steatohepatitis;Journal of Medicinal Chemistry;2022-01-21

5. Design, synthesis, and biological evaluation of a novel dual peroxisome proliferator-activated receptor alpha/delta agonist for the treatment of diabetic kidney disease through anti-inflammatory mechanisms;European Journal of Medicinal Chemistry;2021-06